Screener
CG Oncology CGON Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accounts payable | 7,013 | 608 |
| Accrued expenses and other current liabilities | 9,345 | 8,303 |
| Other liabilities | (654) | — |
| Net cash used in operating activities | (103,357) | (57,236) |
| Investing Activities | ||
| Proceeds from sales and maturities of investments | 479,755 | 370,520 |
| Purchases of investments | (783,400) | (529,852) |
| Issuance of note receivable | — | (26,000) |
Item 1. Financial Statements.
FAQ
- What is CG Oncology's operating cash flow?
- CG Oncology (CGON) reported operating cash flow of -$46.41M in Q2 2026.
- How has CG Oncology's operating cash flow changed year-over-year?
- CG Oncology's operating cash flow decreased by 66.0% year-over-year, from -$27.96M to -$46.41M.
- What is the long-term trend for CG Oncology's operating cash flow?
- Over 2 years (2023 to 2025), CG Oncology's operating cash flow has grown at a 70.2% compound annual growth rate (CAGR), from -$45.68M to -$132.35M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about CG Oncology's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude